Loading...
| Name | Option type | Quality (1-5)↓ | Topics | Created | |
|---|---|---|---|---|---|
Number of pharmaceutical acquisitions by Asahi Kasei by end of 2025  | Categorical | 5 | 7 months ago | ||
Regulatory approval for Asahi Kasei-Calliditas deal by mid-2024? | Binary | 5 | 7 months ago | ||
Asahi Kasei's pharmaceutical revenue up significantly by end of 2025? | Binary | 5 | 7 months ago | ||
Impact on Asahi Kasei's stock price post-Calliditas acquisition announcement | Categorical | 5 | 7 months ago | ||
Integration success of Calliditas into Asahi Kasei  | Categorical | 5 | 7 months ago | ||
Revenue growth of Calliditas Therapeutics post-acquisition | Categorical | 5 | 7 months ago | ||
Asahi Kasei completes acquisition of Calliditas by end of 2024? | Binary | 5 | 7 months ago | ||
Market position of Asahi Kasei's pharma sector by end of 2025 | Categorical | 4 | 7 months ago | ||
Regulatory approval for Asahi Kasei's acquisition of Calliditas by end of 2024? | Binary | 4 | 7 months ago | ||
Market reaction to Asahi Kasei's acquisition announcement | Categorical | 4 | 7 months ago | ||
Asahi Kasei stock price increases post-acquisition? | Binary | 4 | 7 months ago |